Vascular access complications after catheter ablation of ventricular arrhythmias: Impact of vascular closure devices

被引：0

作者：

Tabaja, Chadi ^{[1
]}

Hight, Nolan ^{[1
]}

Younis, Arwa ^{[1
]}

Jadam, Shada ^{[1
]}

Demian, Joe ^{[1
]}

Hussein, Ayman ^{[1
]}

Sroubek, Jakub ^{[1
]}

Saliba, Walid ^{[1
]}

Kanj, Mohamed ^{[1
]}

Bhargava, Mandeep ^{[1
]}

Baranowski, Bryan ^{[1
]}

Callahan, Thomas ^{[1
]}

Chung, Mina ^{[1
]}

Dresing, Thomas ^{[1
]}

Lee, Justin ^{[1
]}

Higuchi, Koji ^{[1
]}

Liuba, Ioan ^{[1
]}

Martin, David ^{[1
]}

Nakhla, Shady ^{[1
]}

Rickard, John ^{[1
]}

Varma, Niraj ^{[1
]}

Taigen, Tyler ^{[1
]}

Wazni, Oussama ^{[1
]}

Santangeli, Pasquale ^{[1
]}

机构：

[1] Cleveland Clin, Dept Cardiovasc Med, Cardiac Electrophysiol Sect, 9500 Euclid Ave, Cleveland, OH 44195 USA

来源：

HEART RHYTHM | 2025年 / 22卷 / 03期

关键词：

Catheter ablation; Outcomes; Vascular access closure; Vascular complications; Ventricular arrhythmias; MAJOR COMPLICATIONS; TACHYCARDIA; COMPRESSION; MORTALITY; TRIAL;

D O I：

10.1016/j.hrthm.2024.09.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BACKGROUND Vascular access site complications are the most frequent complications of percutaneous catheter ablation (CA) of ventricular arrhythmias (VAs). Whether arterial/venous vascular closure devices (VCDs) prevent vascular complications is unknown. OBJECTIVE We investigated the benefit of VCDs in patients undergoing CA of VAs. METHODS Consecutive CA of VAs were included (2018-2022). Vascular accesses were obtained with ultrasound guidance. At the discretion of the operator, arterial and/or venous VCDs were used. Cases were divided into 3 groups: no use of VCDs for any arterial/venous accesses (manual compression [MC]), use of VCDs for some but not all accesses (Partial-VCDs), and use of VCDs for all accesses (Complete-VCDs). Vascular complications were classified as minor if they did not require intervention or major if they required intervention. RESULTS A total of 1016 procedures were performed in 872 patients (mean age 62 +/- 13 years; mean body mass index 30 +/- 6 kg/m2; 27% female) during the study period. Femoral arterial access was obtained in 887 procedures (875 single access: 7.4 +/- 1.5 F size; 12 two accesses: 7.3 +/- 3 and 6.9 +/- 1.8 F). Femoral venous access was obtained in 1014 procedures (unilateral in 17%; bilateral in 83%; mean number of access sites per patient 2.6 +/- 0.7; mean size 8.4 +/- 1.3 F). Hemostasis was achieved with MC in 192 procedures (19%), with Partial-VCD in 275 (27%), and with Complete-VCD in 549 (54%). A vascular complication occurred in 52 procedures (5.1%), including a minor hematoma in 3.9% and/or a major complication in 1.7%. The rate of vascular complications was 6.8% (5.2% minor and 1.6% major) in the MC group, 7.6% (5.1% minor and 3.3% major) in the Partial-VCD group, and 3.3% (2.9% minor and 0.9% major) in the Complete-VCD group (P = .014 for comparison). In multivariable analysis, CompleteVCD remained independently associated with a lower risk of vascular complications (odds ratio 0.69; 95% confidence interval 0.48-0.96; P = .036). CONCLUSION In patients undergoing CA of VAs, Complete-VCD is associated with lower rates of vascular-related complications compared with MC or Partial-VCD.

引用

页码：685 / 692

页数：8

共 14 条

[1] Peichl P., Wichterle D., Pavlu L., Cihak R., Aldhoon B., Kautzner J., Complications of catheter ablation of ventricular tachycardia, Circ Arrhythm Electrophysiol, 7, pp. 684-690, (2014)
[2] Bohnen M., Stevenson W.G., Tedrow U.B., Et al., Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias, Heart Rhythm, 8, pp. 1661-1666, (2011)
[3] Hermiller J.B., Leimbach W., Gammon R., Et al., A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients, J Invasive Cardiol, 27, pp. 129-136, (2015)
[4] Hussain S.K., Eddy M.M., Moorman L., Et al., Major complications and mortality within 30 days of an electrophysiological procedure at an academic medical center: implications for developing national standards, J Cardiovasc Electrophysiol, 26, pp. 527-531, (2015)
[5] Sesana M., Vaghetti M., Albiero R., Et al., Effectiveness and complications of vascular access closure devices after interventional procedures, J Invasive Cardiol, 12, pp. 395-399, (2000)
[6] Martin J.L., Pratsos A., Magargee E., Et al., A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial, Catheter Cardiovasc Interv, 71, pp. 1-5, (2008)
[7] Beraldo de Andrade P., de Ribamar Costa J.J., Rinaldi F.S., Et al., Vascular closure devices attenuate femoral access complications of primary percutaneous coronary intervention, J Invasive Cardiol, 32, pp. 364-370, (2020)
[8] Futyma P., Ciapala K., Sander J., Gluszczyk R., Futyma M., Kulakowski P., Ultrasound-guided venous access facilitated by the Valsalva maneuver during invasive electrophysiological procedures, Kardiol Pol, 78, pp. 235-239, (2020)
[9] Sharma P.S., Padala S.K., Gunda S., Koneru J.N., Ellenbogen K.A., Vascular complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access, J Cardiovasc Electrophysiol, 27, pp. 1160-1166, (2016)
[10] Tanaka-Esposito C.C., Chung M.K., Abraham J.M., Cantillon D.J., Abi-Saleh B., Tchou P.J., Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin, J Interv Card Electrophysiol, 37, pp. 163-168, (2013)

← 1 2 →